Allegheny Neurological Associates

Pittsburgh, Pennsylvania 15212

0 studies enrolling now · 8 studies all time

What they study most

ALS, Acute Brainstem/Cerebellar Syndrome, Amyotrophic Lateral Sclerosis, Focal Epilepsy, Generalized Myasthenia Gravis, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Myasthenia Gravis, Optic Neuritis, Relapse-Remitting Multiple Sclerosis, Transverse Myelitis

Studies at this site

• A Study to Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy — Running, not enrolling
• A Study of RVT-1401 in Myasthenia Gravis (MG) Patients — Completed
• An Efficacy and Safety Study of Ravulizumab in ALS Participants — Stopped early
• Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis — Completed
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) — Completed
• Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis — Completed
• Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis — Completed
• A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose — Completed